Insmed shares slip as CFO Sara Bonstein steps down

** Shares of drugmaker Insmed INSM.O fall more than 3% to $107.59 premarket

** Sara Bonstein to step down as CFO, effective Oct 30

** Sara to remain till month-end to ensure a smooth transition through the company's Q3 financial results reporting on Oct 29

** Prior to joining Insmed, Sara served as the CFO at OncoSec Medical

** Co reaffirms FY26 guidance and has commenced a search to identify the next CFO

** All 25 brokerages covering the stock are bullish; median PT - data compiled by LSEG

** As of last close, stock has fallen 36.15% YTD